Tirzepatide is a dual GIP/GLP-1 receptor agonist made by Eli Lilly, given as a once-weekly subcutaneous injection
For patients managing the complex, overlapping symptoms of Long COVID, ME/CFS, and dysautonomia, targeted L-Lysine supplementation may help alleviate several debilitating issues
Chronic exposure to oxidative stress can lead to inflammation and fibrosis, resulting in impaired kidney function
Calculating Volume with Bacteriostatic Water for Peptides Precision is the soul of science
Improved Metabolic Health: The treatment positively impacts metabolic parameters, potentially leading to lowered blood sugar and improved insulin sensitivity
A passionate educator, he served as Associate Programme Director for Endocrinology at NHG, training the next generation of endocrinologists, and received the NHG Teaching Award for Senior Doctors in 2023